-
1
-
-
0035524114
-
Improving the efficacy of antibody-based cancer therapies
-
P. Carter Improving the efficacy of antibody-based cancer therapies Nat. Rev., Cancer 1 2001 118
-
(2001)
Nat. Rev., Cancer
, vol.1
, pp. 118
-
-
Carter, P.1
-
2
-
-
0034662632
-
Cure of Burkitt's lymphoma in severe combined immunodeficiency mice by T cells, tetravalent CD3xCD19 tandem diabody, and CD28 costimulation
-
B. Cochlovius, S.M. Kipriyanov, M.J. Stassar, J. Schuhmacher, A. Benner, G. Moldenhauer, and M. Little Cure of Burkitt's lymphoma in severe combined immunodeficiency mice by T cells, tetravalent CD3xCD19 tandem diabody, and CD28 costimulation Cancer Res. 60 2000 4336
-
(2000)
Cancer Res.
, vol.60
, pp. 4336
-
-
Cochlovius, B.1
Kipriyanov, S.M.2
Stassar, M.J.3
Schuhmacher, J.4
Benner, A.5
Moldenhauer, G.6
Little, M.7
-
3
-
-
0242384230
-
Design and assembly of anti-CD16 ScFv antibody with two different linker peptides
-
J. Feng, Z. Xie, N. Guo, and B. Shen Design and assembly of anti-CD16 ScFv antibody with two different linker peptides J. Immunol. Methods 282 2003 33
-
(2003)
J. Immunol. Methods
, vol.282
, pp. 33
-
-
Feng, J.1
Xie, Z.2
Guo, N.3
Shen, B.4
-
4
-
-
2342598316
-
The difference of binding epitopes on human CD16 (FcgammaRIII) interacted with hIgG1 and monoclonal antibody B88-9
-
J. Feng, Z. Xie, M. Yu, N. Guo, and B. Shen The difference of binding epitopes on human CD16 (FcgammaRIII) interacted with hIgG1 and monoclonal antibody B88-9 Mol. Immunol. 41 2004 93
-
(2004)
Mol. Immunol.
, vol.41
, pp. 93
-
-
Feng, J.1
Xie, Z.2
Yu, M.3
Guo, N.4
Shen, B.5
-
6
-
-
0036644061
-
Synergistic antitumor effect of bispecific CD19x×CD3 and CD19x×CD16 diabodies in a preclinical model of non-Hodgkin's lymphoma
-
S.M. Kipriyanov, B. Cochlovius, H.J. Schafer, G. Moldenhauer, A. Bahre, F. Le Gall, S. Knackmuss, and M. Little Synergistic antitumor effect of bispecific CD19x×CD3 and CD19x×CD16 diabodies in a preclinical model of non-Hodgkin's lymphoma J. Immunol. 169 2002 137
-
(2002)
J. Immunol.
, vol.169
, pp. 137
-
-
Kipriyanov, S.M.1
Cochlovius, B.2
Schafer, H.J.3
Moldenhauer, G.4
Bahre, A.5
Le Gall, F.6
Knackmuss, S.7
Little, M.8
-
7
-
-
0032700376
-
Bispecific antibodies in cancer therapy, from the laboratory to the clinic
-
R. Koelemij, P.J. Kuppen, C.J. van de Velde, G.J. Fleuren, M. Hagenaars, and A.M. Eggermont Bispecific antibodies in cancer therapy, from the laboratory to the clinic J. Immunother. 22 1999 514
-
(1999)
J. Immunother.
, vol.22
, pp. 514
-
-
Koelemij, R.1
Kuppen, P.J.2
Van De Velde, C.J.3
Fleuren, G.J.4
Hagenaars, M.5
Eggermont, A.M.6
-
8
-
-
0026567963
-
Formation of a bispecific antibody by the use of leucine zippers
-
S.A. Kostelny, M.S. Cole, and J.Y. Tso Formation of a bispecific antibody by the use of leucine zippers J. Immunol. 148 1992 1547
-
(1992)
J. Immunol.
, vol.148
, pp. 1547
-
-
Kostelny, S.A.1
Cole, M.S.2
Tso, J.Y.3
-
9
-
-
0029148633
-
A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity
-
M. Mack, G. Riethmuller, and P. Kufer A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity Proc. Natl. Acad. Sci. U. S. A. 92 1995 7021
-
(1995)
Proc. Natl. Acad. Sci. U. S. A.
, vol.92
, pp. 7021
-
-
MacK, M.1
Riethmuller, G.2
Kufer, P.3
-
10
-
-
0028140247
-
Construction, expression, and activity of a bivalent bispecific single-chain antibody
-
W.D. Mallender, and E.W.J. Voss Construction, expression, and activity of a bivalent bispecific single-chain antibody J. Biol. Chem. 269 1994 199
-
(1994)
J. Biol. Chem.
, vol.269
, pp. 199
-
-
Mallender, W.D.1
Voss, E.W.J.2
-
11
-
-
0031876578
-
An efficient route to human bispecific IgG
-
A.M. Merchant, Z. Zhu, J.Q. Yuan, A. Goddard, C.W. Adams, L.G. Presta, and P. Carter An efficient route to human bispecific IgG Nat. Biotechnol. 16 1998 677
-
(1998)
Nat. Biotechnol.
, vol.16
, pp. 677
-
-
Merchant, A.M.1
Zhu, Z.2
Yuan, J.Q.3
Goddard, A.4
Adams, C.W.5
Presta, L.G.6
Carter, P.7
-
12
-
-
0036671332
-
Bispecific antibodies targeting cancer cells
-
M. Peipp, and T. Valerius Bispecific antibodies targeting cancer cells Biochem. Soc. Trans. 30 2002 507
-
(2002)
Biochem. Soc. Trans.
, vol.30
, pp. 507
-
-
Peipp, M.1
Valerius, T.2
-
13
-
-
0035342590
-
Expression of single-chain Fv-Fc fusions in Pichia pastoris
-
D.B. Powers, P. Amersdorfer, M. Poul, U.B. Nielsen, M.R. Shalaby, G.P. Adams, L.M. Weiner, and J.D. Marks Expression of single-chain Fv-Fc fusions in Pichia pastoris J. Immunol. Methods 251 2001 123
-
(2001)
J. Immunol. Methods
, vol.251
, pp. 123
-
-
Powers, D.B.1
Amersdorfer, P.2
Poul, M.3
Nielsen, U.B.4
Shalaby, M.R.5
Adams, G.P.6
Weiner, L.M.7
Marks, J.D.8
-
14
-
-
0029946383
-
'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization
-
J.B. Ridgway, L.G. Presta, and P. Carter 'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization Protein Eng. 9 1996 617
-
(1996)
Protein Eng.
, vol.9
, pp. 617
-
-
Ridgway, J.B.1
Presta, L.G.2
Carter, P.3
-
17
-
-
0035712627
-
Multimerization of a chimeric anti-CD20 single-chain Fv-Fc fusion protein is mediated through variable domain exchange
-
A.M. Wu, G.J. Tan, M.A. Sherman, P. Clarke, T. Olafsen, S.J. Forman, and A.A. Raubitschek Multimerization of a chimeric anti-CD20 single-chain Fv-Fc fusion protein is mediated through variable domain exchange Protein Eng. 14 2001 1025
-
(2001)
Protein Eng.
, vol.14
, pp. 1025
-
-
Wu, A.M.1
Tan, G.J.2
Sherman, M.A.3
Clarke, P.4
Olafsen, T.5
Forman, S.J.6
Raubitschek, A.A.7
-
18
-
-
0035909785
-
Construction of a bispecific single chain antibody for recruitment of cytotoxic T cells to the tumour stroma associated antigen fibroblast activation protein
-
T. Wuest, D. Moosmayer, and K. Pfizenmaier Construction of a bispecific single chain antibody for recruitment of cytotoxic T cells to the tumour stroma associated antigen fibroblast activation protein J. Biotechnol. 92 2001 159
-
(2001)
J. Biotechnol.
, vol.92
, pp. 159
-
-
Wuest, T.1
Moosmayer, D.2
Pfizenmaier, K.3
-
19
-
-
0242362829
-
A trivalent anti-erbB2/anti-CD16 bispecific antibody retargeting NK cells against human breast cancer cells
-
Z. Xie, M. Shi, J. Feng, M. Yu, Y. Sun, B. Shen, and N. Guo A trivalent anti-erbB2/anti-CD16 bispecific antibody retargeting NK cells against human breast cancer cells Biochem. Biophys. Res. Commun. 311 2003 307
-
(2003)
Biochem. Biophys. Res. Commun.
, vol.311
, pp. 307
-
-
Xie, Z.1
Shi, M.2
Feng, J.3
Yu, M.4
Sun, Y.5
Shen, B.6
Guo, N.7
-
20
-
-
0034087954
-
An efficient route to the production of an IgG-like bispecific antibody
-
Z. Zuo, X. Jimenez, L. Witte, and Z. Zhu An efficient route to the production of an IgG-like bispecific antibody Protein Eng. 13 2000 361
-
(2000)
Protein Eng.
, vol.13
, pp. 361
-
-
Zuo, Z.1
Jimenez, X.2
Witte, L.3
Zhu, Z.4
|